Clinical Trials Directory

Trials / Unknown

UnknownNCT02209662

Safety and Efficacy Study of APIC-PRP in Non-healing Diabetic Foot Ulcers

A Multi-Center, Randomized Trial Comparing the Effectiveness of APIC-PRP to Control, When Added to Standard of Care in the Treatment of Non-healing Diabetic Foot Ulcers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
274 (estimated)
Sponsor
Cytonics Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients have a diabetic foot ulcer that is older than 4 weeks and has been treated with physician-selected standard of care treatment such as debridement, hydrogel or saline irrigation, primary dressing, and offloading will be randomized into one of two groups, the Standard of Care (SoC) or APIC-PRP + SoC. APIC-PRP has high level of platelets that produce growth factors that can help in wound healing.

Conditions

Interventions

TypeNameDescription
DEVICEAPIC-PRPAPIC-PRP
OTHERPlacebo, Saline plus standard of carePlacebo, Saline plus standard of care

Timeline

Start date
2014-10-01
Primary completion
2015-10-01
Completion
2015-12-01
First posted
2014-08-06
Last updated
2014-08-06

Source: ClinicalTrials.gov record NCT02209662. Inclusion in this directory is not an endorsement.

Safety and Efficacy Study of APIC-PRP in Non-healing Diabetic Foot Ulcers (NCT02209662) · Clinical Trials Directory